These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28575382)

  • 21. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay.
    Sharma M; Sethi S; Mishra B; Sengupta C; Sharma SK
    Indian J Med Res; 2003 Feb; 117():76-80. PubMed ID: 12931842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
    Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA
    J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antituberculosis activity of clarithromycin.
    Luna-Herrera J; Reddy VM; Daneluzzi D; Gangadharam PR
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2692-5. PubMed ID: 8593004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
    Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
    Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.
    Juréen P; Werngren J; Hoffner SE
    Tuberculosis (Edinb); 2004; 84(5):311-6. PubMed ID: 15207806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Cavusoglu C; Karaca-Derici Y; Bilgic A
    Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines.
    Viveiros M; Amaral L
    Int J Antimicrob Agents; 2001 Mar; 17(3):225-8. PubMed ID: 11282269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis.
    Hirata T; Saito H; Tomioka H; Sato K; Jidoi J; Hosoe K; Hidaka T
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2295-303. PubMed ID: 8619585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of denaturing HPLC to rapidly identify rifampicin-resistant Mycobacterium tuberculosis in low- and high-prevalence areas.
    Evans JT; Parveen A; Smith GE; Xu L; Chan EW; Chan RC; Hawkey PM
    J Antimicrob Chemother; 2009 Feb; 63(2):295-301. PubMed ID: 19095682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
    Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
    J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.
    Zaw MT; Emran NA; Lin Z
    J Infect Public Health; 2018; 11(5):605-610. PubMed ID: 29706316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The animal experimental study on rifampicin-dependent Mycobacterium tuberculosis].
    Li YL; Luo YA; Zhong M; Chen BW; Shen XB; Su C; Wang GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):617-21. PubMed ID: 17129470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
    van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF
    Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy.
    Parumasivam T; Chan JG; Pang A; Quan DH; Triccas JA; Britton WJ; Chan HK
    Mol Pharm; 2016 Mar; 13(3):979-89. PubMed ID: 26808409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of rifampicin and verapamil combination in multidrug-resistant mycobacterium tuberculosis.
    Demitto Fde O; do Amaral RC; Maltempe FG; Siqueira VL; Scodro RB; Lopes MA; Caleffi-Ferracioli KR; Canezin PH; Cardoso RF
    PLoS One; 2015; 10(2):e0116545. PubMed ID: 25689777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin adjunctive therapy shortens the duration of TB treatment in mice.
    Dutta NK; Bruiners N; Pinn ML; Zimmerman MD; Prideaux B; Dartois V; Gennaro ML; Karakousis PC
    J Antimicrob Chemother; 2016 Jun; 71(6):1570-7. PubMed ID: 26903278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifampicin-resistant tuberculosis.
    Wynne BA; Gupta S
    Lancet; 1995 Oct; 346(8980):971-2. PubMed ID: 7564759
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii.
    Sun Y; Wang L; Li J; Zhao C; Zhao J; Liu M; Wang S; Lu C; Shang G; Jia Y; Wen A
    Eur J Pharmacol; 2014 Apr; 729():116-22. PubMed ID: 24561048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.